IP Verse

Gilead Pharmasset competitive analysis

Latest publications and patents of Gilead Pharmasset New

Explore the latest publications and patents granted to Gilead Pharmasset, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Gilead Pharmasset

EP2709613
Aug 12, 2020Methods For Treating HcvPatent Maintained As Amended
EP1633766
Mar 6, 2019Modified Fluorinated Nucleoside AnaloguesRevoked
EP2227482
Jan 10, 20182',4'-Substituted Nucleosides As Antiviral AgentsNo Opposition Filed Within Time Limit

Latest patents of Gilead Pharmasset opposed by its competitors

Explore Gilead Pharmasset's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2709613
Aug 12, 2020Methods For Treating Hcv1
EP1633766
Mar 6, 2019Modified Fluorinated Nucleoside Analogues1

Latest PTAB cases involving Gilead Pharmasset

Discover the latest PTAB cases involving Gilead Pharmasset, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Gilead Pharmasset

IPR2018-00390Dec 26, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00211Dec 6, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00123Nov 9, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00126Nov 2, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00125Oct 30, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00122Oct 26, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00121Oct 26, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00120Oct 25, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00119Oct 25, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied
IPR2018-00103Oct 25, 2017INITIATIVE FOR MEDICINESGILEAD PHARMASSETInstitution Denied

Peer Comparison New

IP litigation analysis comparing Gilead Pharmasset with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
GILEAD PHARMASSET - 2 - 10Non-Active
GILLARD7 - - - Highly Aggressive
INITIATIVE FOR MEDICINES - - 10 - Highly Aggressive